HMGA2 and hepatocellular carcinoma: Consistent with our findings, previous work in gastric cancer has shown that HMGA2 enhances epithelial‐mesenchymal transitions via the activation of the Wnt/β‐catenin signalling pathway.30 Similarly, in hepatocellular carcinoma, the Wnt/β‐catenin signalling pathway has been found to be activated by HMGA2, which results in inhibited tumour cell proliferation.31